Related Experiment Video
Updated: Jun 26, 2026

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells
Published on: April 2, 2021
Neonatal liver abscesses due to Candida infection effectively treated with caspofungin
Luca Filippi1, Chiara Poggi, Elena Gozzini
1Neonatal Intensive Care Unit, Department of Critical Care Medicine, A. Meyer University Children's Hospital, Florence, Italy. filippi.luca@virgilio.it
Insights
Caspofungin shows promise for treating neonatal candidiasis, a serious infection in premature infants. This antifungal agent was effective in two infants with Candida liver abscesses, even when other drugs failed.
Area of Science:
- Neonatal Medicine
- Pediatric Infectious Diseases
- Pharmacology
Background:
- Neonatal candidiasis is common in intensive care units, especially in preterm infants.
- It has high mortality and is linked to poor neurodevelopmental outcomes.
- Amphotericin B and fluconazole are standard treatments, but alternatives are needed.
Observation:
- Two infants with Candida liver abscesses were treated with caspofungin.
- The first infant received combination therapy including caspofungin.
- The second infant was treated with caspofungin alone.
Findings:
- Caspofungin demonstrated efficacy and tolerability in treating neonatal candidiasis.
- It was effective in cases refractory to conventional antifungal drugs.
- Successful outcomes were achieved in both reported cases.
Implications:
- Caspofungin may be a viable option for neonatal candidiasis, particularly in difficult cases.
- Further research is needed to establish specific dosing and treatment protocols for neonates.
- These findings support exploring caspofungin for invasive fungal infections in infants.
Unlabelled:
Candidiasis is relatively frequent in neonatal and pediatric intensive care units (ICUs), particularly in preterm infants less than 28 weeks of gestational age. Neonatal candidiasis shows high mortality and is often associated to poor neurodevelopmental prognosis in survivor patients. Amphotericin B and fluconazole are the first choice drugs for the treatment of neonatal candidiasis. Caspofungin is an alternative antifungal agent, which is recommended for invasive candidiasis in adults, but has been poorly experienced in neonates and infants as far as now. We report the first two infants with Candida liver abscesses treated with caspofungin. In the first infant bloodstream and liver lesions were cleared by combination therapy with fluconazole, liposomal amphotericin and caspofungin, while in the second one by caspofungin alone.
Conclusion:
Our observations confirm the efficacy and tolerability of caspofungin in the treatment of neonatal candidiasis refractory to conventional antifungal drugs. More extensive data are recommended in order to asses a specific neonatal schedule.
Related Concept Videos
Cryptococcal Meningitis
Candidiasis
Fungal Phylum Microsporidia
Antifungal Agents
